Details for New Drug Application (NDA): 021912

✉ Email this page to a colleague

NDA 021912 describes BROVANA, which is a drug marketed by Lupin and is included in one NDA. It is available from one supplier. Additional details are available on the BROVANA profile page.

The generic ingredient in BROVANA is arformoterol tartrate. There are four drug master file entries for this compound. Eleven suppliers are listed for this compound. Additional details are available on the arformoterol tartrate profile page.

Summary for 021912

Tradename:	BROVANA
Applicant:	Lupin
Ingredient:	arformoterol tartrate
Patents:	0

Pharmacology for NDA: 021912

Mechanism of Action	Adrenergic beta2-Agonists

Suppliers and Packaging for NDA: 021912

Tradename	Generic Name	Dosage	NDA	Application Type	Supplier	National Drug Code	Package Code	Package
BROVANA	arformoterol tartrate	SOLUTION;INHALATION	021912	NDA	Lupin Pharmaceuticals, Inc.	27437-055	27437-055-30	30 POUCH in 1 CARTON (27437-055-30) / 1 VIAL, SINGLE-DOSE in 1 POUCH (27437-055-01) / 2 mL in 1 VIAL, SINGLE-DOSE
BROVANA	arformoterol tartrate	SOLUTION;INHALATION	021912	NDA	Lupin Pharmaceuticals, Inc.	27437-055	27437-055-60	15 POUCH in 1 CARTON (27437-055-60) / 4 VIAL, SINGLE-DOSE in 1 POUCH (27437-055-04) / 2 mL in 1 VIAL, SINGLE-DOSE

Profile for product number 001

Active Rx/OTC/Discontinued:	RX	Dosage:	SOLUTION;INHALATION			Strength	EQ 0.015MG BASE/2ML
Approval Date:	Oct 6, 2006	TE:	AN	RLD:	Yes

Expired US Patents for NDA 021912

Subscribe to access the full database, or Subscribe
Applicant	Tradename	Generic Name	Dosage	NDA	Approval Date	Patent No.	Patent Expiration
Lupin	BROVANA	arformoterol tartrate	SOLUTION;INHALATION	021912-001	Oct 6, 2006	7,145,036	⤷ Subscribe
Lupin	BROVANA	arformoterol tartrate	SOLUTION;INHALATION	021912-001	Oct 6, 2006	7,473,710	⤷ Subscribe
Lupin	BROVANA	arformoterol tartrate	SOLUTION;INHALATION	021912-001	Oct 6, 2006	6,589,508	⤷ Subscribe
Lupin	BROVANA	arformoterol tartrate	SOLUTION;INHALATION	021912-001	Oct 6, 2006	6,866,839	⤷ Subscribe
>Applicant	>Tradename	>Generic Name	>Dosage	>NDA	>Approval Date	>Patent No.	>Patent Expiration

Complete Access Available with Subscription

Make Better Decisions: Try a trial or see plans & pricing

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.